Prof. dr Alvaro Porta, Policlinico di Monza , Italy - hematologist, senior hospital associate:
"The epilogue of this experience is a cooperation with Special Hospital NovaVita, which considers the exchange of patients, medicaments, physicians, experiences, as well as the parameters of treatment outcomes. I assured myself that this therapy is non-toxic, more efficient and cheaper in comparison with the standard chemotherapy".

Hematology, oncology, onco-epidemiology specialists on the professional meeting in the Nova Vita Special Hospital.

Prof. dr. George Mate, oncologist and immunologist from Paris, prof. dr. Neboj ša Arsenijević, Dean at the Faculty of Medicine in Kragujevac:
"In cooperation with the Biofarmgroup, among other things, there have been also tested the therapy effects, which undoubtfully demonstrated a selective effect on the malignant cells by causing their apoptopic death".

"When we got Biofarmgroup preparations on testing we applied our routine methods that are already being used on the human cell level, according to the human cell models and in vitro irradiation by the therapeutic doses of consequent radiation. The results were really unexpected and wonderful and we could immediately distinguish two groups of preparations: the first one has remarkable antitumor and antiproliferative features and they have the same characteristics as cytostatics, and we were specifically interested in another group of preparations, which showed regenerative and radio protective characteristics. Such a high level of radio protection we have never seen in 20 years".

dr Gordana Joksić, specialist, molecular biologist of Institute for Nuclear Sciences Vinča

Dr Nebojša Arsenijević, Dean of the Faculty of Medicine in Kragujevac:

"When my assistant dr. Baskić suggested that we should test the preparations we got from Nova Vita Hospital on our experimental models, at first, I rejected to do so, but then I accepted in order to satisfy his curiosity. My reticence was based on the conventional way of thinking and medical education, because physicians are reserved whenever it is about something that is not based on the well-known facts.

However, even the first experiment showed remarkable results. In in vitro conditions we established that the HLL cells in the 24 hour culture, if exposed to the preparations Korbazol and Nacvonit, show a high level of apoptopic death, practically, it is about a programmed cell death or cell suicide. That percentage depending on doses, varied even to 90% of cells in 24 hours, and when the incubation lasted 48 hours, that percentage was nearly 100. Simultaneously, in the control test tubes in the control groups there were no effects. That means that the examinees' health cells exposed to these preparations did not show any symptom of the apoptopic death".

In the course of three years long researches within the multricentric studies, our most prominent associates were:

Policlinico di Monza - Italy

Instituto di tumori Milano - Italy

Medicinischen hochschole -
Hannover, Deutschland

Vill Joufe - Paris, France

Institut for nuclear science Vinca,
Belgrade - Serbia

University of Bacau - Romania

Nova Vita Representative for Germany:

Volker Gutjahr
Telefon: +49 (0)4637 9636185
Telefax: +49 (0)4637 9636186
Email: volker.gutjahr@t-online.de

Nova Vita Representative for Romania:

dr. Cristina Aosan
Medicina naturista
Telefon: +40 (0)788 41 19 41

Nova Vita Representative for Slovenia:

Joško Oder
Telefon: +386 31 567 731
Email: oder.joze@siol.net

>>top